Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07573527
Effectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Patients With Myofascial Pain SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07573527Not Yet Recruiting
Not Applicable
Effectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Pati...Riphah International Univ...
NCT07573943
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 4
NCT07573943Recruiting
Phase 4
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chron...First Affiliated Hospital...
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07574125
Article Title Impact of Targeted Nutrition Education on Dietary Knowledge, Attitudes, and PracticesUnited Arab Emirates UniversityCompletedNot Applicable
NCT07574125Completed
Not Applicable
Article Title Impact of Targeted Nutrition Education on Dietary Knowledge, Attit...United Arab Emirates Univ...
NCT07573618
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard AnticoagulationWeiwei WuNot Yet RecruitingNot Applicable
NCT07573618Not Yet Recruiting
Not Applicable
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration V...Weiwei Wu
NCT07573085
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health ServicesKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07573085Not Yet Recruiting
Not Applicable
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA)...Karolinska Institutet
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Unknown1 (5%)
not_applicable12 (60%)
Not Specified3 (15%)
Phase 42 (10%)
Phase 22 (10%)
Early Phase 11 (5%)